
Pandemic and All-Hazards Preparedness Act (PAHPA) Policy Brief

Mapping the Patient and Caregiver Journey for Cell and Gene Therapies

Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870
